Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Expeditors International of Wshngtn Inc (EXPD) vs GeneDx Holdings Corp (WGS) Price & Performance

Expeditors International of Wshngtn IncTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Expeditors International of Wshngtn Inc vs GeneDx Holdings Corp — how do they compare? Expeditors International of Wshngtn Inc trades at $181.24 (market cap $23.24B), while GeneDx Holdings Corp trades at $61.39 (market cap $1.96B). The key difference: Expeditors International of Wshngtn Inc is far larger — about 11.9× GeneDx Holdings Corp's market cap, and Expeditors International of Wshngtn Inc pays a 0.91% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.

EXPDWGS
Market Cap
$23.24B$1.96B
Sector
IndustrialsTechnology
52-Week High
$178.22$167.51
52-Week Low
$111.37$34.51
Enterprise Value
$22.49B$1.96B
Dividend Yield
0.91%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Expeditors International of Wshngtn Inc

EXPD trades at $180.87, up 1.49% with strong technical momentum and bullish moving averages. The company demonstrates solid fundamentals with consistent earnings beats, posting Q1 2026 EPS of $1.71 versus $1.33 expected. Revenue grew to $11.07B in 2025 with a 7.48% net margin and impressive 36.59% ROE. Recent dividend of $0.81 reinforces shareholder returns while cash flow trends show operational strength.

Despite trading above the $161.50 consensus target, EXPD's earnings momentum and operational efficiency support continued upside potential. Key risks include analyst skepticism with only 12% buy ratings and overbought technical conditions. The stock's premium valuation requires sustained execution amid transportation industry challenges and economic uncertainties.

GeneDx Holdings Corp

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

About Expeditors International of Wshngtn Inc

Expeditors International of Washington is a non-asset-based third-party logistics provider, mainly focused on international freight forwarding. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. In 2021, Expeditors derived 38% of consolidated net revenue from airfreight, 27% from ocean freight, and 35% from customs brokerage and other services.

Read more on EXPD

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS